Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey

Scandinavian Journal of Gastroenterology

Volumn 43, Issue 7, 2008, Pages 821-830

  Haapamäki, Johanna ^a   Turunen, Ulla ^a   Roine, Risto P ^a   Faärkkilaä, Martti A ^a   Arkkila, Perttu E T ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Crohn's disease; Health related quality of life; HRQOL; IBD; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; STEROID;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; COMORBIDITY; CROHN DISEASE; DELAYED DIAGNOSIS; ENTERITIS; EUROPE; FEMALE; FINLAND; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SYMPTOMATOLOGY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIGESTIVE SYSTEM SURGICAL PROCEDURES; EUROPE; FEMALE; FINLAND; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 46349086857     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520801912011     Document Type: Article

References (22)

1. Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjær M, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101:1274-82.
2. Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, et al. Incidence of Crohn's disease in four counties of southeastern Norway, 1990-93. A prospective population-based study. Scand J Gastroenterol 1996;31:355-61.
3. Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. Scand J Gastroenterol 1996;31:362-6.
4. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804-10.
5. Andersson P, Olaison G, Bendtsen P, Myrelid P, Sjödahl R. Health-related quality of life in Crohn's proctocolitis does not differ from a general population when in remission. Colorect Dis 2003;5:56-62.
6. Carty E, Rampton DS. Evaluation of new therapies for inflammatory bowel disease. Br J Clin Pharmacol 2003;56:351-61.
7. Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 2005;128:862-9.
8. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-76.
9. Van Balkom BPJ, Schoon EJ, Stockbrugger RW, Wolters FL, van Hogezand RA, van Deventer SJH, et al. Effects of antitumour necrosis factor-α therapy on the quality of life in Crohn's disease. Aliment Pharmacol Ther 2002;16:1101-7.
10. McLeod RS, Lavery IC, Leatherman JR, Maryland PA, Fazio VW, Jagelman DG, et al. Factors affecting quality of life with a conventional ileostomy. World J Surg 1986;10:474-9.
11. Michelassi F, Lee J, Rubin M, Fichera A, Kasza K, Karrison T, et al. Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis. Ann Surg 2003;238:433-45.
12. Turina M, Pennington CJ, Kimberling J, Stromberg AJ, Petras RE, Galandiuk S. Chronic pouchitis after ileal pouchanal anastomosis for ulcerative colitis: effect on quality of life. J Gastroent Surg 2006;10:600-6.
13. Delaney CP, Remzi FH, Gramlich T, Dadvand B, Fazio VW. Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis. Ann Surg 2002;236:43-8.
14. Canavan C, Abrams KR, Hawthorne B, Drossman D, Mayberry JF. Long-term prognosis in Crohn's disease: factors that affect quality of life. Aliment Phamacol Ther 2006;23:377-85.
15. Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohn's Colitis 2007;1:10-20.
16. Halme L, Turunen U, Heliö T, Paavola P, Walle T, Miettinen A, et al. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogenous population. Scand J Gastroenterol 2002;37:692-8.
17. Kaipiainen-Seppänen O, Aho K, Heliövaara M. Incidence and prevalence of ankylosing spondylitis in Finland. J Rheumatol 1997;24:496-9.
18. Aho K, Kaipiainen-Seppänen O, Heliövaara M, Klaukka T. Epidemiology of rheumatoid arthritis in Finland. Semin Arthritis Rheum 1998;27:325-34.
19. Schwartz DA, Loftus EV, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002;122:875-80.
20. Travis SPL, Stange EF, Lémann M, Öresland T, Chowers Y, Forbes A, et al. European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006;55 Suppl I:i16-35.
21. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956-63.
22. Thirlby RC, Sobrino MA, Randall JB. The long-term benefit of surgery on health-related quality of life in patients with inflammatory bowel disease. Arch Surg 2001;136:521-7.